Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SERPLULIMAB vs SILDENAFIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SERPLULIMAB vs SILDENAFIL: Safety Overview

Metric SERPLULIMAB SILDENAFIL
Total FAERS Reports 137 35,199
Deaths Reported 36 4,979
Death Rate 26.3% 14.1%
Hospitalizations 81 8,623
Average Patient Age 63.0 yrs 58.3 yrs
% Female Patients 11.1% 33.3%
FDA Approval Date N/A Apr 1, 2015
Manufacturer N/A Northwind Health Company, LLC
Route N/A ORAL
Marketing Status N/A Prescription